183 related articles for article (PubMed ID: 20441243)
1. Effect of atorvastatin on haemostasis, fibrinolysis and inflammation in normocholesterolaemic patients with coronary artery disease: a post hoc analysis of data from a prospective, randomized, double-blind study.
Walter T; Szabo S; Suselbeck T; Borggrefe M; Lang S; Swoboda S; Hoffmeister HM; Dempfle CE
Clin Drug Investig; 2010; 30(7):453-60. PubMed ID: 20441243
[TBL] [Abstract][Full Text] [Related]
2. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
Goicoechea M; de Vinuesa SG; Lahera V; Cachofeiro V; Gómez-Campderá F; Vega A; Abad S; Luño J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S231-5. PubMed ID: 17130267
[TBL] [Abstract][Full Text] [Related]
3. Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects.
Bruni F; Pasqui AL; Pastorelli M; Bova G; Di Renzo M; Cercigani M; Leo A; Auteri A; Puccetti L
Int J Cardiol; 2004 Jun; 95(2-3):269-74. PubMed ID: 15193831
[TBL] [Abstract][Full Text] [Related]
4. Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease.
Seljeflot I; Tonstad S; Hjermann I; Arnesen H
Thromb Res; 2002 Feb; 105(4):285-90. PubMed ID: 12031821
[TBL] [Abstract][Full Text] [Related]
5. Effects of short-term atorvastatin treatment on global fibrinolytic capacity, and sL-selectin and sFas levels in hyperlipidemic patients with coronary artery disease.
Atalar E; Ozmen F; Haznedaroglu I; Açil T; Ozer N; Ovünç K; Aksöyek S; Kes S
Int J Cardiol; 2002 Aug; 84(2-3):227-31. PubMed ID: 12127376
[TBL] [Abstract][Full Text] [Related]
6. Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease.
Undas A; Celinska-Löwenhoff M; Löwenhoff T; Szczeklik A
J Thromb Haemost; 2006 May; 4(5):1029-36. PubMed ID: 16689755
[TBL] [Abstract][Full Text] [Related]
7. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.
Krysiak R; Okopień B; Herman Z
Drugs; 2003; 63(17):1821-54. PubMed ID: 12921488
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia.
Tehrani S; Mobarrez F; Antovic A; Santesson P; Lins PE; Adamson U; Henriksson P; Wallén NH; Jörneskog G
Thromb Res; 2010 Sep; 126(3):e225-31. PubMed ID: 20637495
[TBL] [Abstract][Full Text] [Related]
9. Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation.
Lai WT; Lee KT; Chu CS; Voon WC; Yen HW; Tsai LY; Sheu SH
Int J Cardiol; 2005 Feb; 98(3):459-64. PubMed ID: 15708180
[TBL] [Abstract][Full Text] [Related]
10. NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin.
Satoh M; Tabuchi T; Itoh T; Nakamura M
Clin Sci (Lond); 2014 Feb; 126(3):233-41. PubMed ID: 23944632
[TBL] [Abstract][Full Text] [Related]
11. Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease.
Waehre T; Damås JK; Gullestad L; Holm AM; Pedersen TR; Arnesen KE; Torsvik H; Frøland SS; Semb AG; Aukrust P
J Am Coll Cardiol; 2003 May; 41(9):1460-7. PubMed ID: 12742282
[TBL] [Abstract][Full Text] [Related]
12. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease--a randomized, placebo-controlled study.
Alber HF; Frick M; Suessenbacher A; Doerler J; Schirmer M; Stocker EM; Dichtl W; Pachinger O; Weidinger F
Am Heart J; 2006 Jan; 151(1):139. PubMed ID: 16368305
[TBL] [Abstract][Full Text] [Related]
13. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
[TBL] [Abstract][Full Text] [Related]
14. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
Joukhadar C; Klein N; Prinz M; Schrolnberger C; Vukovich T; Wolzt M; Schmetterer L; Dorner GT
Thromb Haemost; 2001 Jan; 85(1):47-51. PubMed ID: 11204586
[TBL] [Abstract][Full Text] [Related]
15. Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin.
Trifiletti A; Lasco A; Scamardi R; Pizzoleo MA; Gaudio A; La Rocca R; Morini E; Frisina N
Pathophysiol Haemost Thromb; 2003; 33(2):84-7. PubMed ID: 14624049
[TBL] [Abstract][Full Text] [Related]
16. The effect of rapid lipid lowering with atorvastatin on autonomic parameters in patients with coronary artery disease.
Szramka M; Harriss L; Ninnio D; Windebank E; Brack J; Skiba M; Krum H
Int J Cardiol; 2007 Apr; 117(2):287-91. PubMed ID: 16889854
[TBL] [Abstract][Full Text] [Related]
17. Effects of atorvastatin on reactive hyperaemia and the thrombosis-fibrinolysis system in patients with heart failure.
Tousoulis D; Antoniades C; Bosinakou E; Kotsopoulou M; Tsioufis C; Tentolouris C; Trikas A; Pitsavos C; Stefanadis C
Heart; 2005 Jan; 91(1):27-31. PubMed ID: 15604328
[TBL] [Abstract][Full Text] [Related]
18. Impact of atorvastatin treatment in first-degree relatives of patients with premature coronary artery disease with endothelial dysfunction: a double-blind, randomized, placebo-controlled crossover trial.
Hong SJ; Chang HJ; Park S; Kang DR; Shin S; Cho IJ; Shim CY; Hong GR; Ha JW; Chung N
Clin Cardiol; 2013 Aug; 36(8):480-5. PubMed ID: 23754711
[TBL] [Abstract][Full Text] [Related]
19. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis.
Bustos C; Hernández-Presa MA; Ortego M; Tuñón J; Ortega L; Pérez F; Díaz C; Hernández G; Egido J
J Am Coll Cardiol; 1998 Dec; 32(7):2057-64. PubMed ID: 9857893
[TBL] [Abstract][Full Text] [Related]
20. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?
Piorkowski M; Fischer S; Stellbaum C; Jaster M; Martus P; Morguet AJ; Schultheiss HP; Rauch U
J Am Coll Cardiol; 2007 Mar; 49(10):1035-42. PubMed ID: 17349882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
